Cipla’s arm to acquire 30% stake in Brandmed

17 Apr 2019 Evaluate

Cipla’s South Africa-based subsidiary--- Cipla Medpro will acquire 30 percent stake in the connected healthcare firm Brandmed (Pty) for an upfront cash consideration of ZAR 65 million (nearly Rs 32 crore).

The company will also pay certain milestone payment for the stake acquisition over a period of three years, subject to meeting agreed profit targets. This transaction will help to transition healthcare from being reactive to a proactive and real-time monitoring model that focuses on promoting wellness instead of managing illness.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. The company’s portfolio includes over 1500 products across wide range of therapeutic categories with one quality standard globally.

Cipla Share Price

1463.10 2.50 (0.17%)
09-Jan-2026 11:03 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1749.50
Dr. Reddys Lab 1210.85
Cipla 1463.10
Zydus Lifesciences 905.95
Lupin 2184.50
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×